New combined therapy helps extend lives of men with prostate cancer



New combined therapy helps extend lives of men with prostate cancer

Practice-changing research shows that a combination of androgen deprivation therapy — a commonly used hormone injection — plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years.

Materials provided by Cedars-Sinai Medical Center. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

31st March 2023

Form is (mal)function: Protein's shape lets bacteria disarm it

Read more
30th March 2023

Researchers discover a way to fight the aging process and cancer development

Read more
30th March 2023

Researchers identify cell type that could be key to preventing marrow transplant complication

Read more